Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-186923
Filing Date
2026-04-28
Accepted
2026-04-28 16:05:11
Documents
14
Period of Report
2026-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A bolt-20260424.htm   iXBRL DEF 14A 981304
2 GRAPHIC img117169523_0.jpg GRAPHIC 16109
3 GRAPHIC img117169523_1.jpg GRAPHIC 329667
4 GRAPHIC img117169523_2.jpg GRAPHIC 147240
  Complete submission text file 0001193125-26-186923.txt   2511163

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20260424.xsd EX-101.SCH 8289
17 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20260424_htm.xml XML 3229
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39988 | Film No.: 26907566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)